Verdence Capital Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-834
| Closed | -$6.77K | – | 560 |
|
|
2023
Q1 | $6.77K | Hold |
834
| – | – | ﹤0.01% | 536 |
|
|
2022
Q4 | $9.88K | Hold |
834
| – | – | ﹤0.01% | 494 |
|
|
2022
Q3 | $12K | Hold |
834
| – | – | ﹤0.01% | 516 |
|
|
2022
Q2 | $29K | Hold |
834
| – | – | ﹤0.01% | 507 |
|
|
2022
Q1 | $33K | Sell |
834
-1,214
| -59% | -$48K | ﹤0.01% | 508 |
|
|
2021
Q4 | $87K | Hold |
2,048
| – | – | 0.01% | 491 |
|
|
2021
Q3 | $139K | Hold |
2,048
| – | – | 0.02% | 481 |
|
|
2021
Q2 | $158K | Buy |
2,048
+1,214
| +146% | +$93.7K | 0.02% | 467 |
|
|
2021
Q1 | $55K | Hold |
834
| – | – | 0.01% | 431 |
|
|
2020
Q4 | $28K | Sell |
834
-429
| -34% | -$14.4K | 0.01% | 408 |
|
|
2020
Q3 | $69K | Buy |
+1,263
| New | +$69K | 0.02% | 361 |
|